Gene · 1439
Papers1,845
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,845
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The fibroblast growth factor-Klotho axis at molecular level. | Open Life Sci | 2023 | 37941788 | PubTator, text mining | PubMed |
| Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma. | BMC Cancer | 2023 | 37940859 | PubTator, text mining | PubMed |
| Idiopathic pulmonary fibrosis with benign SFTPC variant and pathogenic MARS1 mutations: can't see the forest for the trees! | ERJ Open Res | 2023 | 37936900 | PubTator, text mining | PubMed |
| The m6A/m1A/m5C-Related Methylation Modification Patterns and Immune Landscapes in Rheumatoid Arthritis and Osteoarthritis Revealed by Microarray and Single-Cell Transcriptome. | J Inflamm Res | 2023 | 37933335 | PubTator, text mining | PubMed |
| Prediction of anti-TNF therapy failure in ulcerative colitis patients by ensemble machine learning: A prospective study. | Heliyon | 2023 | 37928018 | PubTator, text mining | PubMed |
| Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma. | Cancer Res Commun | 2023 | 37910143 | PubTator, text mining | PubMed |
| Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4. | Int J Mol Sci | 2023 | 37894816 | PubTator, text mining | PubMed |
| TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors. | Biomedicines | 2023 | 37893178 | PubTator, text mining | PubMed |
| Role of autoantibodies targeting interferon type 1 in COVID-19 severity: A systematic review and meta-analysis. | J Transl Autoimmun | 2023 | 37868109 | PubTator, text mining | PubMed |
| Analysis of shared ceRNA networks and related-hub genes in rats with primary and secondary photoreceptor degeneration. | Front Neurosci | 2023 | 37811327 | PubTator, text mining | PubMed |
| Research progress of neonatal hypoxic-ischemic encephalopathy in nonhuman primate models. | Ibrain | 2023 | 37786551 | PubTator, text mining | PubMed |
| Harnessing Immune Response in Acute Myeloid Leukemia. | J Clin Med | 2023 | 37762763 | PubTator, text mining | PubMed |
| Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications. | Int J Mol Sci | 2023 | 37762066 | PubTator, text mining | PubMed |
| Effect of Carbamylated Erythropoietin in a Chronic Model of TNBS-Induced Colitis. | Biomedicines | 2023 | 37760938 | PubTator, text mining | PubMed |
| Banff Human Organ Transplant Consensus Gene Panel for the Detection of Antibody Mediated Rejection in Heart Allograft Biopsies. | Transpl Int | 2023 | 37745639 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis and experimental validation reveals hub genes of rheumatoid arthritis. | Exp Ther Med | 2023 | 37745040 | PubTator, text mining | PubMed |
| The link between psoriasis and other diseases based on epidemiological and genetic analyses. | Postepy Dermatol Alergol | 2023 | 37692276 | PubTator, text mining | PubMed |
| Expanding the mutational and clinical spectrum of Chinese intellectual disability patients with two novel CTCF variants. | Front Pediatr | 2023 | 37664546 | PubTator, text mining | PubMed |
| Anti-TNF Therapy Regulates Phagosome Pathway by Inhibiting NCF4 Expression to Treat Ankylosing Spondylitis. | J Musculoskelet Neuronal Interact | 2023 | 37654221 | PubTator, text mining | PubMed |
| A new era of macrophage-based cell therapy. | Exp Mol Med | 2023 | 37653035 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1439/papers?page=6